25 Nov

Resignation of Director

MedAdvisor Limited ACN 145 327 617 Level 2, 971 Burke Road Camberwell Vic 3124 mymedadvisor.com/investors MARKET RELEASE Resignation of Director Melbourne, Australia, 25 November, 2021 - Medtech company, MedAdvisor Limited ( MedAdvisor or the Company ) (ASX: MDR) announces that Mr Peter Bennetto has resigned as a director of the Company, effective from 26 November 2021. Mr Bennetto has been a director of MedAdvisor Limited (formerly Exalt Resources Limited) since 28 November 2013. He is the Company’s longest serving director and served as Chairman from November 2013 to February 2020. Board Chair Chris Ridd said, “ " Peter was instrumental from the early days in helping to steer MedAdvisor's growth and was also a key contributor to the Adheris acquisition last year. I want to acknowledge Peter as former Chair of the company for his long service and I know that he leaves at a time when he can proudly look back on the achievements to date and with confidence about the future outlook." Managing Director and CEO, Robert Read added, “ Peter has had extraordinary passion, insight and commitment that has helped MedAdvisor achieve significant growth since listing. I would like to thank him for his support as both our initial Chair and then as a non-executive director .” Commenting on his time on the MedAdvisor Board, Mr Bennetto said, “ It has been my absolute pleasure to work with such a committed group of people on a mission to improve peoples’ lives .” - ENDS – This document has been authorised for release by Naomi Lawrie, MedAdvisor Company Secretary. 2 About MedAdvisor MedAdvisor is a world-class medication management platform that empowers patients to simply manage their medication and improve adherence. MedAdvisor’s highly automated and intuitive software system connects patients to tools and education materials from their preferred pharmacy. MedAdvisor works with 25,000 pharmacies in the US to deliver programs to help patients take their medication safely and effectively. In Australia, MedAdvisor has connected over 2.3 million patients through more than 65% of Australian pharmacies. MedAdvisor has partnered with Cotiviti in the US and is on track to become one of the largest players in the global digital adherence market. In 2018 and 2020, MedAdvisor was recognised in the AFR Fast 100. Visit: mymedadvisor.com/investors For more information: Simon Glover Chief Financial Officer corporate@medadvisor.com.au +61 3 905 3036 Greer Quinn Media relations greer@forwardcomm.com.au 0433 753 557
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from MedAdvisor Limited (ASX:MDR) when you join Listcorp.